Brief: GlycoMimetics On Dec 19 Nasdaq Grants Glycomimetics 180 Days To Regain Compliance
26/12/2024 22:00
Dec 26 (Reuters) - GlycoMimetics Inc GLYC.O :
* GLYCOMIMETICS INC - ON DEC 19, NASDAQ GRANTS GLYCOMIMETICS
180
DAYS TO REGAIN COMPLIANCE
Further company coverage: GLYC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crescent Biopharma
See all newsBrief: Crescent Biopharma - Potential To Initiate First CR-001 Phase 3 Study In Early 2028
Brief: Crescent Biopharma Announces FDA Clearance Of Ind Application For CR-002, A Pd-L1-Targeted Topoisomerase Inhibitor Adc, For The Treatment Of Solid Tumors
Crescent Biopharma posts smaller-than-expected Q2 net loss
U.S. STOCKS ON THE MOVE-Cintas, Veradermics
Crescent Biopharma slips on $125 mln share offering